Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure

Kidney International

Volumn 56, Issue 4, 1999, Pages 1313-1316

  Schelling, Jeffrey R ^a,b   Cleveland, Ronald P ^b  

^a Division of Nephrology   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Cell death; Chronic renal failure; Diabetic nephropathy; Tubular atrophy

Indexed keywords

FAS LIGAND;

ANIMAL TISSUE; APOPTOSIS; ATROPHY; CELL HYPERPLASIA; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE EPITHELIUM; LIGAND BINDING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032872911     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00684.x     Document Type: Conference Paper

References (31)

1. RISDON RA, SLOPER JC, DE WARDENER HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2:363-366, 1968
2. SCHAINUCK LI, STRIKER GE, CUTLER RE, BENDITT EP: Structuralfunctional correlations in renal disease. Hum Patlwl 1:631-641, 1970
3. BOHLE A, MACKENSEN-HAEN S, VON GISE H: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 7:421-433, 1988
4. PREISIG PA, FRANCII HA: Renal epithelial cell hyperplasia and hypertrophy. Semin Neplirol 15:327-340, 1995
5. WOLF O: Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury. Miner Electrolyte Metab 21:303-316, 1995
6. BOHLE A, MULLER GA, WEIIRMANN M, MACKENSEN-HAEN S, XIAO J-C: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Am J Kidney Dis 49(Suppl):S2-S9, 1996
7. FINE LG, ORPIIANIDES C, NORMAN JT: Progressive renal disease: The chronic hypoxia hypothesis. Kidney hit 65:S74-S78, 1998
8. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
9. MAJNO G, JORIS I: Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Palhol 146:3-15, 1995
10. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N EngU Med 333:18-25, 1995
11. BODI I, ABRAHAM AA, KIMMEL PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26:286291, 1995
12. SUGIYAMA H, KASHIHARA N, MAKINO H, YAMASAKI Y, OTA Z: Apoptosis in glomerular sclerosis. Kidney lut 49:103-111, 1996
13. SCHUMER M, COLOMBEL MC, SAWCZUK IS, GOBE G, CONNOR J, O'TooLE KM, OLSSON CA, WISE GJ, BUTTYAN R: Morphologic, biochemical, and molecular evidence of apoptosis during reperfusion phase after brief periods of renal ischemia. Am J Palhol 140:831-838, 1992
14. NAGATA S: Apoptosis by death factor. Cell 88:355-365, 1997
15. LEITHAUSER F, DIIEIN J, MECIITERSHEIMER G, KORETZ K, BRUDERLEIN S, SCHMIDT A, DEBATIN KM, KRAMMER PH, MOLLER P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429, 1993
16. ORTIZ-ARDUAN A, DANOFF TM, KALLURI R, GONZALEZ-CUADRADO S, KARP SL, ELKON K, EGIDO J, NEILSON EG: Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 271:F1193-F1201, 1996
17. GODLEY LA, KOPP JB, ECKHAUS M, PAGLINO JJ, OWENS J, VARMUS HE: Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10:836850, 1996
18. ZALUPS RK: The Os/+ mouse: A genetic animal model of reduced renal mass. Am J Physio! 264:F53-F60, 1993
19. GAVRIELI Y, SIIERMAN Y, BEN-SASSON SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. / Cell Biol 119:493-501, 1992
20. SCHELLING JR, GENTRY DJ, DUBYAK GR: Annexin II inhibition of G protein-regulated inositol trisphosphate formation in rat aortic smooth muscle. Am J Pliysiol 270:F6S2-F690, 1996
21. RACUSEN LC, MONTEIL C, SGRIGNOLI A, LUCSKAY M, MAROUILLAT S, RIIIM JGS, MORIN JP: Cell lines with extended in vitro growth potential from human renal proximal tubule: Characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 129:318-329, 1997
22. CLEVELAND RP, Liu YC: CD4 expression by erythroid precursor cells in human bone marrow. Blood 87:2275-2282, 1996
23. GALLE PR, HOFMANN WJ, WALCZAK H, SCHALLER H, OTTO G, STREMMEL W, KRAMMER PH, RUNKEL L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230, 1995
24. GIORDANO C, STASSI G, DE MARIA R, TODARO M, RICHIUSA P, PAPOFF G, RUBERTI G, BAGNASCO M, TESTI R, GALLUZZO A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963, 1997
25. BODI I, ABRAHAM AA, KIMMEL PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26:286291, 1995
26. COLUCCI WS: Apoptosis in the heart. N EnglJ Med 335:1224-1226, 1996
27. O'CONNELL J, O'SULLIVAN GC, COLLINS JK, SlIANAHAN F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. / Exp Med 184:1075-1082, 1996
28. DOWLING P, SIIANG OF, RAVAL S, MENONNA J, COOK S, HUSAR W: Involvement of the CD95 (APO-1/Fas) receptor/Iigand system in multiple sclerosis brain, y Exp Med 184:1513-1518, 1996
29. KONDO T, SUDA T, FUKUYAMA H, ADACIII M, NAGATA S: Essential roles of the Fas ligand in the development of hepatitis. Nat Med 4:409-413, 1997
30. TAKEMURA T, MURAKAMI K, MIYAZATO H, YAGI K, YOSHIOKA K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 48:1886-1892, 1995
31. BOONSTRA JG, VAN DER WOUDE FJ, WEVER PC, LATERVEER JC, DAIIA MR, VAN KOOTEN C: Expression and function of Fas (CD95) on human renal tubular epithelial cells. JA m SocNephrol 8:15171524, 1997